| ★ |  Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment | | 46 | Estados Unidos | |
| 17 |  Are GLP1’s For Everyone? Which One Is Right For You? | Talking With Docs @talkingwithdocs | 191.9K | Canadá | 87 |
| 16 |  GLP-1’s: The Pharma “Accident” that keeps on giving | | 3.9K | — | 87 |
| 19 |  Unlocking Weight Loss Secrets No Plateaus, Diabetes Reversed! #weightloss #retatrutide #glp1 | Dr. G's Lifestyle Medicine Network @gooddrg | 2.8K | Estados Unidos | 86 |
| 11 |  Do GLP-1s Work for Depression—or Is It Metabolism? | Metabolic Mind @metabolicmind | 2.5K | Estados Unidos | 87 |
| 15 |  Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | | 1.6K | Estados Unidos | 87 |
| 6 |  GLP-1 Therapies: Where We’ve Been & Where We’re Going | Conversations on Health Care @cohcpodcast | 541 | Estados Unidos | 87 |
| 4 |  Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 87 |
| 10 |  T1D Case Study: She Has Better Control With Blood Sugars Automated? | | 445 | Estados Unidos | 87 |
| 12 |  Insulin Stacking Done Right: How It Improved My Blood Sugar Control | | 381 | Estados Unidos | 87 |
| 3 |  TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 87 |
| 14 |  Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | 87 |
| 7 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 87 |
| 13 |  Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3 | | 158 | Estados Unidos | 87 |
| 9 |  Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes | | 143 | Estados Unidos | 87 |
| 20 |  Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026 | | 114 | Estados Unidos | 86 |
| 18 |  GLP-1 Weight Loss Drugs : Miracle Cure or Costly Mistake? ( Facts vs Hype ) | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 113 | Estados Unidos | 87 |
| 1 |  Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 88 |
| 8 |  ZUPREME-1: Petrelintide Reduces Obesity, Maintains Tolerability in Phase 2 Trial | | 81 | Estados Unidos | 87 |
| 2 |  Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 87 |
| 5 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 87 |